Cargando…

The Complex Roles and Therapeutic Implications of m(6)A Modifications in Breast Cancer

Accumulating evidence indicates that N(6)-methyladenosine (m(6)A), which directly regulates mRNA, is closely related to multiple biological processes and the progression of different malignancies, including breast cancer (BC). Studies of the aberrant expression of m(6)A mediators in BC revealed that...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wei, Min, Bai, Jing-Wen, Niu, Lei, Zhang, Yong-Qu, Chen, Hong-Yu, Zhang, Guo-Jun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Cell and Developmental Biology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7829551/ https://www.ncbi.nlm.nih.gov/pubmed/33505967 http://dx.doi.org/10.3389/fcell.2020.615071

Ejemplares similares

m(6)A Modification Mediates Mucosal Immune Microenvironment and Therapeutic Response in Inflammatory Bowel Disease
por: Chen, Yongyu, et al.
Publicado: (2021)

Non-Coding RNA m6A Modification in Cancer: Mechanisms and Therapeutic Targets
por: Chen, Da-Hong, et al.
Publicado: (2021)

Histone Modifications and Chondrocyte Fate: Regulation and Therapeutic Implications
por: Wan, Chao, et al.
Publicado: (2021)

Regulatory Role of N6-Methyladenosine (m6A) Modification in Osteoarthritis
por: Zhai, Ganggang, et al.
Publicado: (2022)

The Pivotal Role of Chemical Modifications in mRNA Therapeutics
por: Liu, Albert, et al.
Publicado: (2022)

Analysis of m6A Methylation Modification Patterns and Tumor Immune Microenvironment in Breast Cancer
por: Dong, Menglu, et al.
Publicado: (2022)

m(6)A Modification Involves in Enriched Environment-Induced Neurogenesis and Cognition Enhancement
por: Qu, Wenzheng, et al.
Publicado: (2022)

Diagnostic, Therapeutic, and Prognostic Value of the m(6)A Writer Complex in Hepatocellular Carcinoma
por: Gu, Zongting, et al.
Publicado: (2022)

A Broad m6A Modification Landscape in Inflammatory Bowel Disease
por: Nie, Kai, et al.
Publicado: (2022)

CRISPR-based m(6)A modification and its potential applications in telomerase regulation
por: Yi, Mingliang, et al.
Publicado: (2023)

The m(6)A RNA Modification Modulates Gene Expression and Fibrosis-Related Pathways in Hypertrophic Scar
por: Liu, Si-Yu, et al.
Publicado: (2021)

Comprehensive Analysis of the Transcriptome-Wide m6A Methylation Modification Difference in Liver Fibrosis Mice by High-Throughput m6A Sequencing
por: Fan, Chang, et al.
Publicado: (2021)

RNA m(6)A Modification in Immunocytes and DNA Repair: The Biological Functions and Prospects in Clinical Application
por: Zhou, Mingjie, et al.
Publicado: (2021)

m6A Regulator-Associated Modification Patterns and Immune Infiltration of the Tumor Microenvironment in Hepatocarcinoma
por: Li, Jianhao, et al.
Publicado: (2021)

Identification of m(6)A Regulator-Associated Methylation Modification Clusters and Immune Profiles in Melanoma
por: Du, Fengying, et al.
Publicado: (2021)

Identification of New m(6)A Methylation Modification Patterns and Tumor Microenvironment Infiltration Landscape that Predict Clinical Outcomes for Papillary Renal Cell Carcinoma Patients
por: Zheng, Bin, et al.
Publicado: (2022)

N(6)-Methyladenosine RNA Modification: An Emerging Immunotherapeutic Approach to Turning Up Cold Tumors
por: Zhan, Lei, et al.
Publicado: (2021)

m(6)A Modification in Mammalian Nervous System Development, Functions, Disorders, and Injuries
por: Yu, Jun, et al.
Publicado: (2021)

The Emerging Role of m6A Modification in Regulating the Immune System and Autoimmune Diseases
por: Wang, Yimeng, et al.
Publicado: (2021)

New insights on the interplays between m(6)A modifications and microRNA or lncRNA in gastrointestinal cancers
por: Su, Tao, et al.
Publicado: (2023)

METTL3 Contributes to Osteosarcoma Progression by Increasing DANCR mRNA Stability via m6A Modification
por: Zhou, Xinying, et al.
Publicado: (2022)

Therapeutic and Mechanistic Perspectives of Protein Complexes in Breast Cancer
por: Waterhouse, Mark P., et al.
Publicado: (2019)

SLC2A1 is a Diagnostic Biomarker Involved in Immune Infiltration of Colorectal Cancer and Associated With m6A Modification and ceRNA
por: Liu, Xu-Sheng, et al.
Publicado: (2022)

Corrigendum: METTL3 contributes to osteosarcoma progression by increasing DANCR mRNA stability via m6A modification
por: Zhou, Xinying, et al.
Publicado: (2023)

The Biological Function, Mechanism, and Clinical Significance of m6A RNA Modifications in Head and Neck Carcinoma: A Systematic Review
por: Jing, Feng-Yang, et al.
Publicado: (2021)

RNA m(6)A Modification Plays a Key Role in Maintaining Stem Cell Function in Normal and Malignant Hematopoiesis
por: Wang, Peipei, et al.
Publicado: (2021)

Effect, Mechanism, and Applications of Coding/Non-coding RNA m6A Modification in Tumor Microenvironment
por: Si, Chaohua, et al.
Publicado: (2021)

The Role of m6A Regulator-Mediated Methylation Modification and Tumor Microenvironment Infiltration in Glioblastoma Multiforme
por: Wang, Liang, et al.
Publicado: (2022)

Novel Insights Into the Multifaceted Functions of RNA n(6)-Methyladenosine Modification in Degenerative Musculoskeletal Diseases
por: Li, Hengzhen, et al.
Publicado: (2021)

RNA Demethylase FTO Mediated RNA m(6)A Modification Is Involved in Maintaining Maternal-Fetal Interface in Spontaneous Abortion
por: Qiu, Weiyu, et al.
Publicado: (2021)

m6A demethylase FTO and osteoporosis: potential therapeutic interventions
por: Huang, Mei, et al.
Publicado: (2023)

Editorial: Protein modifications in epigenetic dysfunctional diseases: mechanisms and potential therapeutic strategies
por: Ji, Jing, et al.
Publicado: (2023)

Risk Score Prediction Model of Prognosis in GC Patients by Age and Gender Combined With m6A Modification Genes FTO and RBM15
por: Yue, Limin, et al.
Publicado: (2022)

Uncovering N4-Acetylcytidine-Related mRNA Modification Pattern and Landscape of Stemness and Immunity in Hepatocellular Carcinoma
por: Liu, Sicheng, et al.
Publicado: (2022)

The Latest Research Progress of m(6)A Modification and Its Writers, Erasers, Readers in Infertility: A Review
por: Liu, Xuda, et al.
Publicado: (2021)

Characterization of m6A Regulator-Mediated Methylation Modification Patterns and Tumor Microenvironment Infiltration in Ovarian Cancer
por: Luo, Yihong, et al.
Publicado: (2022)

The emerging role of m(6)A modification of non-coding RNA in gastrointestinal cancers: a comprehensive review
por: Wang, Meiqi, et al.
Publicado: (2023)

Signaling pathways governing the maintenance of breast cancer stem cells and their therapeutic implications
por: Ordaz-Ramos, Alejandro, et al.
Publicado: (2023)

N(6)-Methyladenosine RNA Modification: A Potential Regulator of Stem Cell Proliferation and Differentiation
por: Wei, Bo, et al.
Publicado: (2022)

Quantitative Analysis of Methylated Adenosine Modifications Revealed Increased Levels of N(6)-Methyladenosine (m(6)A) and N(6),2′-O-Dimethyladenosine (m(6)Am) in Serum From Colorectal Cancer and Gastric Cancer Patients
por: Hu, Yiqiu, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_a4mp2gqf14husm4p9pilfr6rvj